Trial intelligence / Profile preview

Ovarian Hormone Regulation of Hemodynamics

NCT05057546Phase 4Active, not recruiting

Sponsor
University of Colorado Denver
Start
Nov 2021
Primary completion
Sep 2024
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of degarelix, sponsored by University of Colorado Denver. Started Nov 2021; status: active, not recruiting.

02

Drugs

degarelix

Beyond the preview

Go deeper on NCT05057546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05057546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call